COVID-19: Health Ministry asks AIOCD to ensure availability of critical drugs management of virus

Health ministry has forwarded a list of 55 drugs for ICU management of Covid-19 patients and a list of 96 drugs for general availability and treatment of various other health conditions. The list was prepared following a detailed exercise undertaken by the Director General Health Services.

The Union Ministry for Health and Family Welfare (MoHF&W) has written to the All India Organisation of Chemists and Druggists (AIOCD) conveying that its member should ensure availability of critical drugs for management of COVID-19 and other essential drugs during these critical conditions.

The combination of hydorxychloroquine and azithromycin has been prescribed for severe patients requiring ICU management. The letter also stated that other drugs are also currently under various stages of trials, but have so far not been recommended for use in India.

“In light of this current pandemic, it is absolutely essential that sufficient market availability of these drugs, along with other essential drugs is ensured by your members. These steps will go a long way in the effective clinical management of the pandemic. I would request to you to kindly convey this message to your members, so that adequate availability of the essential medicines can be ensured during this challenging time of COVID-19,” the letter stated.

Jagannath Sakharam Shinde, President, AIOCD said that, “Still all of us have to work hard for some more time and carefully dispense drugs like hydroxychloroquine and azithromycin which are mandated to be sold on prescriptions only. Hope you shall circulate this message to all your chemists and stockiest in your states. Social media may be used for immediate delivery. Our preparedness is must in this demanding situation as carers of needy patients are looking to us for instant life savings medicines,”.
The letter also stated that “in accordance with the Clinical Management Guidelines for COVID-19, hydroxychloroquine has been recommended as prophylaxis for certain categories like healthcare workers and household contacts of positive cases.”

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India